:: Volume 26, Issue 5 (Bimonthly 2022) ::
Feyz 2022, 26(5): 530-538 Back to browse issues page
The effect of eight weeks respiratory rehabilitation training on pulmonary and functional indices in patient with COVID-19 referred to Beheshti Hospital Kashan
Fatemeh Abbasi , Rasul Eslami * , Minoo Bassami
Department of Exercise Physiology, Faculty of Physical Education and Sports Sciences, Allameh Tabataba'i University, Tehran, I.R. Iran. , rasul@yahoo.com
Abstract:   (605 Views)
Background: Rare studies have been done about rehabilitation stage in patients with COVID-19.
Materials and Methods: In randomized controlled clinical trial, thirty Participants were randomly divided to control group (CG) and intervention group (IG). Participants in IG group performed rehabilitation trainings 30 minutes once a day for two 4 weeks. Forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), FEV1/FVC and forced expiratory flow (FEF) 25-75% were measured using spirometry. Six-min walk distance [6-MW) test as well as heart rate (HR) and blood oxygen saturation (SPO2) were measured, also.
Results: Twenty-eight patients completed the study. FVCact, FEV1act, FEV1pred, FEV1/FVCact, FEV1/FVCPred were significantly improved in intervention group as compared to control group (Ptime*group FVCact= 0.01, Ptime*group FEV1act< 0.001, Ptime*group FEV1pred< 0.001, Ptime*group FEV1/FVCact= 0.01, Ptime*group FEV1/FVCpred< 0.01). In addition, changes in FVCpred and PEFact became significant after the adjustments [Ptime*group FVCpred= 0.03, Ptime*group PEFact= 0.05). Finally, no significant differences were seen in changes of rest heart rate (RHR) (Ptime*group: 0.55), walk heart rate (WHR) (Ptime*group: 0.61), walked distance (Ptime*group: 0.41), and PEFpred [Ptime*group= 0.09) throughout the study between the two groups.
Conclusion: This study illustrated rehabilitation training significantly increased FVC, FEV1, FEV1/FVC, and PEFact, while it had no significant influence on PEFpred, RHR, WHR and walk distance after 8-weeks. However, further RCTs are needed to confirm our findings.
Keywords: Pulmonary Rehabilitation, COVID-19, Respiratory function, Lung disease
Full-Text [PDF 358 kb]   (290 Downloads)    
Type of Study: Research | Subject: medicine, paraclinic
Received: 2022/07/14 | Revised: 2023/01/25 | Accepted: 2022/11/8 | Published: 2022/12/4
1. Liu L, Miller HJ, Scheff J. The impacts of COVID-19 pandemic on public transit demand in the United States. Plos One 2020; 15(11): e0242476.
2. Elibol E. Otolaryngological symptoms in COVID-19. Eur Arch Oto-Rhino-Laryngol 2021; 278(4): 123.
3. Abdi M. Coronavirus disease 2019 [COVID-19] outbreak in Iran: Actions and problems. Infect Cont Hosp Epidemiol 2020; 41(6): 754-5.
4. Mannino DM, Gagnon RC, Petty TL, Lydick E. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Internal Med 2000; 160(11): 1683-9.
5. Hentsch L, Cocetta S, Allali G, Santana I, Eason R, Adam E, et al. Breathlessness and COVID-19: A Call for Research. Respiration 2021; 100(10): 1016-26.
6. Graham HR, Bagayana SM, Bakare AA, Olayo BO, Peterson SS, Duke T, et al. Improving hospital oxygen systems for COVID-19 in low-resource settings: lessons from the field. Glob Health 2020; 8(4): 858-62.
7. Augustin IM, Franssen FM, Houben-Wilke S, Janssen DJ, Gaffron S, Pennings HJ, et al. Multidimensional outcome assessment of pulmonary rehabilitation in traits-based clusters of COPD patients. Plos One 2022; 17(2): e0263657.
8. Curci C, Pisano F, Bonacci E, Camozzi DM, Ceravolo C, Bergonzi R, et al. Early rehabilitation in post-acute COVID-19 patients: data from an Italian COVID-19 Rehabilitation Unit and proposal of a treatment protocol. Eur J Phys Rehabil Med 2020: 633-41.
9. Liu K, Zhang W, Yang Y, Zhang J, Li Y, Chen Y. Respiratory rehabilitation in elderly patients with COVID-19: A randomized controlled study. Complement Ther Clin Pract 2020; 39: 101166.
10. Zhu P, Wang Z, Guo X, Feng Z, Chen C, Zheng A, et al. Pulmonary rehabilitation accelerates the recovery of pulmonary function in patients with COVID-19. Front Cardiovasc Med 2021; 8. [in Print]
11. Reychler G, Piraux E, Beaumont M, Caty G, Liistro G. Telerehabilitation as a Form of Pulmonary Rehabilitation in Chronic Lung Disease: A Systematic Review. Healthcare 2022; 10(9).
12. Rayegani SM, Bozorgmehr R, Oshnari LA, Kaghazi AHM. The Effect of Exercise-Based Pulmonary Rehabilitation on Quality of Life in Recovered COVID-19 Patients; a Quasi-Experimental Study. Arch Acad Emerg Med 2022; 10(1): e45-e.
13. Mashhadi M, Sahebozamani M, Daneshjoo A, Adeli SH. The Effect of Selected Respiratory and Core Stability Tele Exercises on Pulmonary Function and Functional Capacity in Covid-19 Survivors: A Randomized Clinical Trial. Physical Phys Ther 2022; 12(2): 0-.
14. Sun T, Guo L, Tian F, Dai T, Xing X, Zhao J, et al. Rehabilitation of patients with COVID-19. Exp Rev Resp Med 2020; 14(12): 1249-56.
15. Bressi B, Paltrinieri S, Fugazzaro S, Costi S. Respiratory rehabilitation in elderly patients with COVID-19: A randomized controlled study. Complement Ther Clin Pract 2021; 43: 101368.
16. Gloeckl R, Leitl D, Jarosch I, Schneeberger T, Nell C, Stenzel N, et al. Benefits of pulmonary rehabilitation in COVID-19: a prospective observational cohort study. ERJ Open Res 2021; 7(2).
17. Kwon CH, Rhee EJ, Song JU, Kim JT, Kwag HJ, Sung KC. Reduced lung function is independently associated with increased risk of type2 diabetes in Korean men. Cardiovasc Diabetol 2012; 11(1): 1-8.
18. Daniela M, Catalina L, Ilie O, Paula M, Daniel-Andrei I, Ioana B. Effects of Exercise Training on the Autonomic Nervous System with a Focus on Anti-Inflammatory and Antioxidants Effects. Antioxidants 2022; 11(2): 350.
19. Heffernan KS, Ranadive SM, Jae SY. Exercise as medicine for COVID-19: On PPAR with emerging pharmacotherapy. Med Hypoth 2020; 143: 110197.
20. Ora J, Prendi E, Ritondo BL, Pata X, Spada F, Rogliani P. Pulmonary rehabilitation in noncystic fibrosis bronchiectasis. Respiration 2022; 101(1): 97-105.

XML   Persian Abstract   Print

Creative Commons License
This open access journal is licensed under a Creative Commons Attribution-NonCommercial ۴.۰ International License. CC BY-NC ۴. Design and publishing by Kashan University of Medical Sciences.
Copyright ۲۰۲۳© Feyz Medical Sciences Journal. All rights reserved.
Volume 26, Issue 5 (Bimonthly 2022) Back to browse issues page